Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...

MONDAY, July 1, 2024 -- Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer...

TUESDAY, July 2, 2024 -- Transgender and gender-diverse individuals have a higher risk for experiencing all forms of violence compared with cisgender...

New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...

A recent study by researchers at Washington University School of Medicine in St. Louis sheds new light on the risks associated with cannabis use...

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of...

Women who are unscreened or under-screened are at greater risk of developing cervical cancer, the government says.

A new study suggests that certain drugs used to treat enlarged prostate may also reduce the risk of developing dementia with Lewy bodies (DLB). This...